Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series

BACKGROUND: Mycobacterium abscessus (M. abscessus) pulmonary disease is a refractory chronic infectious disease. Options for treating M. abscessus pulmonary disease are limited, especially in outpatient settings. Among parenteral antibiotics against M. abscessus, intravenous amikacin (AMK) is expect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Infect Dis
Main Authors: Namkoong, Ho, Morimoto, Kozo, Nishimura, Tomoyasu, Tanaka, Hiromu, Sugiura, Hiroaki, Yamada, Yoshitake, Kurosaki, Atsuko, Asakura, Takanori, Suzuki, Shoji, Fujiwara, Hiroshi, Yagi, Kazuma, Ishii, Makoto, Tasaka, Sadatomo, Betsuyaku, Tomoko, Hoshino, Yoshihiko, Kurashima, Atsuyuki, Hasegawa, Naoki
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4977760/
https://ncbi.nlm.nih.gov/pubmed/27506679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-016-1689-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados